Middle east respiratory syndrome coronavirus (MERS-CoV): A perpetual challenge

Annals of Saudi Medicine

Volumn 33, Issue 5, 2013, Pages 427-436

  Al Hajjar, Sami ^a,d   Memish, Ziad A ^b,d   McIntosh, Kenneth ^c  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b MINISTRY OF HEALTH   (Saudi Arabia)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; MIDDLE EAST; RESPIRATORY TRACT INFECTIONS; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERITY OF ILLNESS INDEX;

EID: 84891145091     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.5144/0256-4947.2013.427     Document Type: Review

References (67)

1. De Groot RJ,, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, et al. Middle East Respiratory Syndrome Coronavirus (MER S-CoV): Announcement of the Coronavirus Study Group. J Virol. 2013 Jul; 87(14): 7790-2.
2. WHO. Clinical management of severe acute respiratory infections when novel coronavirus is suspected: What to do and what not to do http://www.who.int/csr/disease/coronavirus-infections/InterimGuidance- ClinicalManagement-NovelCoronavirus-11Feb13u.pdf.
3. WHO. Middle East respiratory syndrome coronavirus (MER S-CoV) - update. http://www.who.int/csr/don/2013-10-04/en/index.html http://www.who.int/csr/don/ 2013-08-29/en/index.html http://www.who.int/csr/disease/coronavirus-infections/ update-20130813/en/
4. P M Penttinen K Kaasik-Aaslav, A Friaux, A Donachie, B Sudre, et al. Taking stock of the first 133 MER S coronavirus cases globally Is the epidemic changing? Eurosurveillance, 2013: 18 (39, 26) :1-5.
5. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367:1814-20.
6. The Health Protection Agency (HPA) UK Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Euro Surveill. 2013;18(11): p ii=20427. Available from: http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=20427.
7. CDC. Clusters Under Investigations. Accessed on September 7, 2013 Available from: http://www.cdc.gov/coronavirus/mers/mers-clusters.
8. Hijawi. B, Abdallat. M, Sayadeh. A, Alqasrawi. S A. Haddadin,. et al. s from a retrospective investigation. Novel coronavirus infections in Jordan, April 2012: epidemiological finding. EMHJ, 2013:19(1): S12-18.
9. Tyrrel, D. A. J., J. D. Almedia, D. M. Berry, C. H. Cunningham, D. Hamre, M. S. Hofstad, L. Malluci, and K. McIntosh. Coronavirus. Nature 1968; 220:650.
10. McIntosh, K. Coronaviruses: a comparative review. Curr. Top. Mi-crobiol. Immunol. 1974;63:85-129.
11. Van der Hoek L. Human coronaviruses: what do they causȩ Antivir Ther (Lond) 2007; 12: 651-58.
12. Leen Vijgen, Els Keyaerts, Elien Moes, Inge Thoelen, Elke Wollants et al Complete Genomic Sequence of Human Coronavirus OC43: Molecular Clock Analysis Suggests a Relatively Recent Zoonotic Coronavirus Transmission Event. J. Virol. 2005; 79 (3) 1595-1604.
13. Bermingham A, Chand MA, Brown CS, Aarons E, Tong C, Langrish C, et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012; 17(40):p ii=20290. Available from: http://www.Eurosurveillance. org/ViewArticle.aspx?ArticleId=20290.
14. Buchholz U, Muller MA, Nitsche, Sanewski A, Wevering N, Bauer-Balci T, et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill. 2013;18(8):p ii=20406. Available from: http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=20406. PMid: 23449231.
15. Gulland A. Novel coronavirus spreads to Tunisia. BMJ. 2013; 346:f3372. http://dx.doi.org/10.1136/bmj.f3372. PMid: 23704132.
16. Gulland A. Two cases of novel coronavirus are confirmed in France. BMJ. 2013; 346:f3114. http://dx.doi.org/10.1136/bmj.F3114. PMid: 23674339.
17. Puzelli S, Azzi A, Santini MG, Di Martino A, Facchini M, Castrucci MR, et al. Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-?CoV) infection in Florence, Italy, May to June 2013. Euro Surveill. 2013;18(34):pii=20564. Available from: http://www.Eurosurveillance. org/ViewArticle.aspx?ArticleId=20564. PMid: 23987829.
18. CDC. Updated Information on the Epidemiology of Middle East Respiratory Syndrome Coronavirus (MER S-CoV) Infection and Guidance for the Public, Clinicians, and Public Health Authorities, 2012-2013. 2013 :62(38);793-796
19. V M Corman, I Eckerle, T Bleicker, A Zaki, O Landt et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Eurosurveillance, 2012; 17 (39): 1-6/2012;17(49): 1-9
20. S, Guggemos W, Kallies R, Muth D, Junglen S, Muller MA, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 2013:13; 745-751
21. Benoit Guery, Julien Poissy, Loubna el Mansouf, Caroline Séjourné, Nicolas Ettahar. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus:a report of nosocomial transmission. The Lancet, 2013:381(9885); 2265-2272.
22. Memish ZA, M.D., Alimuddin I. Zumla, Md.D, PhD. Rafat F. Al-Hakeem, M.D., Abdullah A. Al-Rabeeah, M.D et al. Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections. N Engl J Med 2013; 368:2487-2494.
23. Augustina Annan, Heather J. Baldwin, Victor Max Corman, Stefan M. Klose, Human Betacoronavirus 2c EMC/2012related Viruses in Bats, Ghana and Europe Emerging Infectious Diseases. 2011; 19(3): 456-9.
24. Matthew Cotten Ph D, Simon J Watson Ph D, Prof Paul Kellam Ph D, Abdullah A Al-Rabeeah FRC S, Hatem Q Makhdoom Ph D, et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. The Lancet, Early Online Publication, 20 September 2013 doi:10.1016/S0140-6736(13) 61887-5.
25. Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, et al. Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia. Emerg Infect Dis. 2013;19(11). http://dx.doi.org/10.3201/eid1911.131172.
26. Reusken CB, Haagmans BL, Muller MA, Gutierrez C, Godeke GJ, Meyer B, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 8 Aug 2013.
27. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MER S coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18(36):pii=20574. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 20574.
28. Muller MA, Raj VS, Muth D, et al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio 2012; 3:e00515-1.
29. Laurence Josset, Vineet D. Menachery, Lisa E. Gralinski, Sudhakar Agnihothram et al. Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus. mBio 2013 4(3):e00165-13. Doi: 10.1128/mBio.00165-13.
30. Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013; 495:251-4.
31. Vincent J. Munster, Emmie de Wit, Heinz Feldmann Pneumonia from Human Coronavirus in a Macaque Mode. N Engl J Med 2013: 368; 16: 1560-2
32. Morbidity and Mortality Weekly Report (MMWR). Update: Severe Respiratory Illness Associated with Middle East Respiratory Syndrome Coronavirus (MER S-CoV) Worldwide, 2012-2013. June 7, 2013 / Vol. 62.
33. Middle East respiratory syndrome coronavirus. Joint Kingdom of Saudi Arabia/WHO mission. Riyadh, 4-9 June 2013 http://www.who.int/csr/disease/ coronavirus-infections/MERSCov-WHO-KSA-Mission-Jun13-.pdf.
34. Abdullah Assiri, M.D., Allison McGeer, M.D., Trish M. Perl, M.D., Connie S. Price et al. Hospital outbreak of middle east respiratory syndrome coronavirus. N Engl J Med 2013; 369(5): 407-16.
35. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-6.
36. Lancet 2003;361:1832.]
37. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003; 300: 1961-6.
38. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003; 300:1966-70.
39. Dye C, Gay N. Modeling the SARS epidemic. Science 2003;300:1884-5.
40. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Tor-onto, Canada. CMAJ 2003;169:285-92.
41. Breban R, Riou J, Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 2013; published online July 5. DOI: 10.1016/ S0140-6736(13)61492-0.
42. Abdullah Assiri, Jaffar A Al-Tawfiq, Abdullah A Al-Rabeeah, Fahad A Al-Rabiah, Sami Al-Hajjar, et al. Epidemiological, demographic and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study?. The Lancet Infectious Diseases, Volume 13, Issue 9, Pages 752-761
43. Ali M. AlBarrak, MD, Gwen M. Stephens, MD, MSc, Roger Hewson, Ph D, Ziad A. Memish, MD. Recovery from severe novel coronavirus infection. Saudi Med J 2012; Vol. 33 (12): 1265-1269
44. Joseph S.M. Peiris, M.D., D.Phil., Kwok Y. Yuen, M.D., Albert D.M.E. Osterhaus, Ph.D., and Klaus Stohr, Ph.D. The Severe Acute Respiratory Syndrome. N Engl J Med 2003;349:2431-41.
45. Hui DS, Chan PK. Severe acute respiratory syndrome and coronavirus. Infect Dis Clin North Am 2010; 24: 619-38.
46. Lee N, Hui DS, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348: 1986-94.?
47. Yieh KM, Peng MY, Lin JC, Wang NC, Chang FY. Clinical and laboratory features in the early stage of severe acute respiratory syndrome. J Microbiol Immunol Infect 2006; 39: 45-53.
48. Booth CM, Matukas M, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801-09.
49. Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013 Jun 29; 381(9885):2265-72.
50. WHO. Revised interim case definition for reporting to WHO Middle East respiratory syndrome coronavirus (MER S-CoV). http://www.who.int/csr/disease/ coronavirus-infections/case-definition/en/index.html.
51. Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, et al. Detection of a novel human coronavirus by real-time reverse transcription polymerase chain reaction. Euro Surveill 2012(17): pii=20285.
52. WHO Laboratory testing for novel coronavirus (Available from http://www.who.int/csr/disease/coronavirus-infections/en/index.html
53. Corman VM, Muller MA, Costabel U, Timm J, Binger T, Meyer B, Kreher P.et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012 Dec 6; 17(49). pii: 20334.
54. CDC. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Patients Under Investigation (PUIs) for Middle East Respiratory Syndrome Coronavirus (MER S-CoV) - Version 2 http://www.cdc.gov/coronavirus/ mers/guidelines-clinical-specimens.html.
55. CDC. Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Middle East Respiratory Syndrome (MERS). http://www.cdc.gov/coronavirus/mers/downloads/Interim-MERS-Lab-Biosafety- Guidelines.pdf. June 7, 2013.
56. WHO. Interim surveillance recommendations for human infection with Middle East respiratory syndrome coronavirus. http://www.who.int/csr/disease/ coronavirus-infections/InterimRevisedSurveillanceRecommendations-nCoVinfection- 27Jun13.pdf.
57. Chan JF, Chan KH, Choi GK, et al. Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation. J Infect Dis 2013;207:1743-52.
58. Kindler E, Jónsdóttir HR, Muth D, et al. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio 2013; 4:e00611-12.
59. C Reusken, H Mou, G J Godeke, L van der Hoek, B Meyer, et al. Specific serology for emerging human coronaviruses by protein microarray. Eurosurveillance, Volume 18, Issue 14, 04 April 2013.
60. K-H Chan et al. Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. J Infection 2013: S0163-4453
61. WHO. Infection prevention and control during health care for probable or confirmed cases of novel coronavirus (nCoV) infectionInterim guidance. http://www.who.int/csr/disease/coronavirus-infections/IPCnCoVguidance-06May13. pdf.
62. International Severe Acute Respiratory & Emerging Infection Consortium (ISARIC). Treatment of MER S-CoV: Decision Support Tool Clinical Decision Making Tool for Treatment of MER S-CoV v.1.1, 29 July, 2013. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317139281416.
63. Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. European Journal of Clinical Microbiology & Infectious Diseases 2005; 24:44-6.
64. Tzong-shi Chiiueh, L.K. Situ, Jung-Chung Lin, Paul K.S. Chan, Ming-Yieh Peng et. al. Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital. Journal of Antimicrobial Chemotherapy (2005): 56; 919-922.
65. Adran H. de, Wilde, V. Stalin Raj, Diede Oudshoorn, Theo M. Bestebroer, Stefan van Nieuwkoop et al. MER S-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-? treatment. J Gen Virol 2013: 94 (8);1749-1760.
66. Darryl Falzarano, Emmie de Wit, Cynthia Martellaro, Julie Callison, Vincent J. Munster& Heinz Feldmann Inhibition of novel ? coronavirus replication by a combination of interferon-?2b and ribavirin. http://www.nature.com/srep/2013/130418/srep01686/pdf/srep01686.pdf.
67. Chan KS, Lai ST, Chu CM, Tsui E, Tam CY, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: A multicentre retrospective matched cohort study. Hong Kong Med J 2003; 9: 399-406.